14-3-3β and γ differentially regulate peroxisome proliferator activated receptor γ₂ transactivation and hepatic lipid metabolism

Keyphrases

• Peroxisome Proliferator-activated Receptor 100%
• Transactivation 100%
• Receptor 2 100%
• Hepatic Lipid Metabolism 100%
• Glucose Metabolism 66%
• Expression Level 66%
• Non-alcoholic Fatty Liver Disease (NAFLD) 66%
• Lipid Metabolism 66%
• 14-3-3 Protein 66%
• Target Molecule 33%
• High Concentration 33%
• Metabolic Disorders 33%
• Cell Signaling Pathways 33%
• Hepatocytes 33%
• Lipid Accumulation 33%
• Transcriptional Regulator 33%
• Free Fatty Acids 33%
• Transcriptional Activity 33%
• Therapeutic Target 33%
• Lipogenesis 33%
• High Free Fatty Acid 33%
• Hepatic Lipogenesis 33%
• Hepatic Lipid Accumulation 33%
• Lipid Transport 33%
• Obesity Diabetes 33%
• Fatty Liver Disease 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Peroxisome Proliferator Activated Receptor 100%
• Fatty Acid 100%
• Nonalcoholic Fatty Liver 100%
• Protein 14 3 3 100%
• Metabolic Disorder 50%
• Fatty Liver 50%